Szepeshazi, K., Schally, A. V., Halmos, G., Lamharzi, N., Groot, K., & Horvath, J. E. (1997). A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers. The National Academy of Sciences of the USA.

Szepeshazi, Karoly, Andrew V. Schally, Gabor Halmos, Najib Lamharzi, Kate Groot, and Judit E. Horvath. A Single in Vivo Administration of Bombesin Antagonist RC-3095 Reduces the Levels and MRNA Expression of Epidermal Growth Factor Receptors in MXT Mouse Mammary cancers. The National Academy of Sciences of the USA, 1997.

Szepeshazi, Karoly, et al. A Single in Vivo Administration of Bombesin Antagonist RC-3095 Reduces the Levels and MRNA Expression of Epidermal Growth Factor Receptors in MXT Mouse Mammary cancers. The National Academy of Sciences of the USA, 1997.